Moreover, the gene GPBP1L1 has a great impact in both LGG and GBM patient survival and showed distinct downregulation in oligodendroglioma when compared to both astrocytoma and GBM, but its role in cancer is still not described. This evidence concerns the gene GPBP1L1 and astrocytoma (excluding glioblastoma).